The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)picolinamide ID: ALA551051
Cas Number: 827591-02-6
PubChem CID: 11416123
Max Phase: Preclinical
Molecular Formula: C18H16ClN3O
Molecular Weight: 325.80
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N[C@@H]1CCCc2c1[nH]c1ccc(Cl)cc21)c1ccccn1
Standard InChI: InChI=1S/C18H16ClN3O/c19-11-7-8-14-13(10-11)12-4-3-6-15(17(12)21-14)22-18(23)16-5-1-2-9-20-16/h1-2,5,7-10,15,21H,3-4,6H2,(H,22,23)/t15-/m1/s1
Standard InChI Key: WJQBOBGVBBZLJU-OAHLLOKOSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-4.3018 3.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0163 3.3295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0163 2.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3018 2.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5873 2.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5873 3.3295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8027 2.2495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3178 2.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8027 3.5844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4671 4.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6466 4.4243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1617 3.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4973 3.0032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0124 2.3358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1874 2.3358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2251 1.6213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2251 3.0502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1874 0.9068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2251 0.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0501 0.1923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4627 0.9068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0502 1.6213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7308 3.7420 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 5 1 0
6 9 1 0
7 8 1 0
13 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 1
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
16 22 2 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
2 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.80Molecular Weight (Monoisotopic): 325.0982AlogP: 4.02#Rotatable Bonds: 2Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.48CX Basic pKa: 2.10CX LogP: 3.55CX LogD: 3.55Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -1.07
References 1. Gudmundsson KS, Boggs SD, Sebahar PR, Richardson LD, Spaltenstein A, Golden P, Sethna PB, Brown KW, Moniri K, Harvey R, Romines KR.. (2009) Tetrahydrocarbazole amides with potent activity against human papillomaviruses., 19 (15): [PMID:19556128 ] [10.1016/j.bmcl.2009.06.001 ] 2. Okesli-Armlovich A, Gupta A, Jimenez M, Auld D, Liu Q, Bassik MC, Khosla C.. (2019) Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening., 29 (18): [PMID:31420268 ] [10.1016/j.bmcl.2019.08.010 ] 3. Boschi D, Pippione AC, Sainas S, Lolli ML.. (2019) Dihydroorotate dehydrogenase inhibitors in anti-infective drug research., 183 [PMID:31557612 ] [10.1016/j.ejmech.2019.111681 ]